Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI). more
| Time Frame | XBI | S&P500 |
|---|---|---|
| 1-Week Return | 4.08% | -0.08% |
| 1-Month Return | 1.76% | 2.89% |
| 3-Month Return | 17.31% | 4.25% |
| 6-Month Return | 26.81% | 11.33% |
| 1-Year Return | 85.62% | 21.19% |
| 3-Year Return | 97.91% | 73.03% |
| 5-Year Return | 25.79% | 73.65% |
| 10-Year Return | 155.12% | 253.03% |
| Time Frame | XBI | S&P500 |
|---|---|---|
| 1-Week Return | 704.60% | -4.09% |
| 1-Month Return | 23.65% | 41.43% |
| 3-Month Return | 91.07% | 18.39% |
| 6-Month Return | 61.87% | 24.31% |
| 1-Year Return | 85.62% | 21.19% |
| 3-Year Return | 25.55% | 20.05% |
| 5-Year Return | 4.70% | 11.67% |
| 10-Year Return | 9.82% | 13.44% |
| Stock name | Ticker | Weight |
|---|---|---|
APOGEE THERAPEUTICS INC | APGE | 1.57% |
TWIST BIOSCIENCE CORP | TWST | 1.56% |
PRAXIS PRECISION MEDICINES I | PRAX | 1.49% |
ORUKA THERAPEUTICS INC | ORKA | 1.49% |
INSMED INC | INSM | 1.39% |
DIANTHUS THERAPEUTICS INC | DNTH | 1.39% |
PROTAGONIST THERAPEUTICS INC | PTGX | 1.34% |
SPYRE THERAPEUTICS INC | SYRE | 1.33% |
REVOLUTION MEDICINES INC | RVMD | 1.33% |
ERASCA INC | ERAS | 1.32% |
CG ONCOLOGY INC | CGON | 1.32% |
KYMERA THERAPEUTICS INC | KYMR | 1.31% |
TRAVERE THERAPEUTICS INC | TVTX | 1.29% |
COGENT BIOSCIENCES INC | COGT | 1.29% |
RHYTHM PHARMACEUTICALS INC | RYTM | 1.26% |
VAXCYTE INC | PCVX | 1.25% |
REGENERON PHARMACEUTICALS | REGN | 1.24% |
RELAY THERAPEUTICS INC | RLAY | 1.21% |
ROIVANT SCIENCES LTD | ROIV | 1.19% |
BRIDGEBIO PHARMA INC | BBIO | 1.19% |
NATERA INC | NTRA | 1.18% |
HALOZYME THERAPEUTICS INC | HALO | 1.18% |
ARROWHEAD PHARMACEUTICALS IN | ARWR | 1.17% |
CYTOKINETICS INC | CYTK | 1.17% |
VIKING THERAPEUTICS INC | VKTX | 1.16% |
AMGEN INC | AMGN | 1.16% |
SCHOLAR ROCK HOLDING CORP | SRRK | 1.15% |
MODERNA INC | MRNA | 1.13% |
ACADIA PHARMACEUTICALS INC | ACAD | 1.1% |
INCYTE CORP | INCY | 1.09% |
VERTEX PHARMACEUTICALS INC | VRTX | 1.07% |
ALKERMES PLC | ALKS | 1.07% |
BIOMARIN PHARMACEUTICAL INC | BMRN | 1.06% |
UNIQURE NV | QURE | 1.06% |
ABBVIE INC | ABBV | 1.05% |
MADRIGAL PHARMACEUTICALS INC | MDGL | 1.05% |
DYNE THERAPEUTICS INC | DYN | 1.04% |
GILEAD SCIENCES INC | GILD | 1.04% |
TG THERAPEUTICS INC | TGTX | 1.03% |
BIOGEN INC | BIIB | 1.03% |
CELCUITY INC | CELC | 1.02% |
CRISPR THERAPEUTICS AG | CRSP | 1.01% |
KRYSTAL BIOTECH INC | KRYS | 1% |
IMMUNOVANT INC | IMVT | 0.99% |
SELLAS LIFE SCIENCES GROUP I | SLS | 0.98% |
SUMMIT THERAPEUTICS INC | SMMT | 0.98% |
MIRUM PHARMACEUTICALS INC | MIRM | 0.97% |
NEUROCRINE BIOSCIENCES INC | NBIX | 0.96% |
EXELIXIS INC | EXEL | 0.96% |
UNITED THERAPEUTICS CORP | UTHR | 0.95% |
PTC THERAPEUTICS INC | PTCT | 0.93% |
ULTRAGENYX PHARMACEUTICAL IN | RARE | 0.92% |
BEAM THERAPEUTICS INC | BEAM | 0.89% |
IMMUNITYBIO INC | IBRX | 0.89% |
GRAIL INC | GRAL | 0.88% |
IOVANCE BIOTHERAPEUTICS INC | IOVA | 0.88% |
BIOCRYST PHARMACEUTICALS INC | BCRX | 0.86% |
VIRIDIAN THERAPEUTICS INC | VRDN | 0.86% |
DENALI THERAPEUTICS INC | DNLI | 0.83% |
VERA THERAPEUTICS INC | VERA | 0.82% |
CELLDEX THERAPEUTICS INC | CLDX | 0.82% |
IDEAYA BIOSCIENCES INC | IDYA | 0.81% |
TANGO THERAPEUTICS INC | TNGX | 0.81% |
ADMA BIOLOGICS INC | ADMA | 0.76% |
IMMUNOME INC | IMNM | 0.75% |
ARCUTIS BIOTHERAPEUTICS INC | ARQT | 0.75% |
MINERALYS THERAPEUTICS INC | MLYS | 0.74% |
SAREPTA THERAPEUTICS INC | SRPT | 0.73% |
DISC MEDICINE INC | IRON | 0.72% |
IONIS PHARMACEUTICALS INC | IONS | 0.72% |
ALNYLAM PHARMACEUTICALS INC | ALNY | 0.72% |
ARCUS BIOSCIENCES INC | RCUS | 0.71% |
RECURSION PHARMACEUTICALS A | RXRX | 0.68% |
SYNDAX PHARMACEUTICALS INC | SNDX | 0.68% |
VERACYTE INC | VCYT | 0.67% |
KODIAK SCIENCES INC | KOD | 0.66% |
INTELLIA THERAPEUTICS INC | NTLA | 0.63% |
AGIOS PHARMACEUTICALS INC | AGIO | 0.62% |
PALVELLA THERAPEUTICS INC | PVLA | 0.62% |
NURIX THERAPEUTICS INC | NRIX | 0.6% |
NOVAVAX INC | NVAX | 0.57% |
BIOHAVEN LTD | BHVN | 0.53% |
VERICEL CORP | VCEL | 0.52% |
CAREDX INC | CDNA | 0.5% |
STOKE THERAPEUTICS INC | STOK | 0.49% |
PRECIGEN INC | PGEN | 0.48% |
ZENAS BIOPHARMA INC | ZBIO | 0.42% |
VIR BIOTECHNOLOGY INC | VIR | 0.42% |
ANAPTYSBIO INC | ANAB | 0.42% |
ABSCI CORP | ABSI | 0.42% |
CULLINAN THERAPEUTICS INC | CGEM | 0.42% |
ORIC PHARMACEUTICALS INC | ORIC | 0.41% |
HYPERLIQUID STRATEGIES | PURR | 0.41% |
FIRST TRACKS BIOTHERAPEU W/I | TRAX | 0.41% |
VOR BIOPHARMA INC | VOR | 0.41% |
CORVUS PHARMACEUTICALS INC | CRVS | 0.4% |
XENCOR INC | XNCR | 0.38% |
AVALO THERAPEUTICS INC | AVTX | 0.37% |
TYRA BIOSCIENCES INC | TYRA | 0.37% |
ARDELYX INC | ARDX | 0.35% |
REPLIMUNE GROUP INC | REPL | 0.34% |
TAYSHA GENE THERAPIES INC | TSHA | 0.34% |
ANNEXON INC | ANNX | 0.34% |
INHIBRX BIOSCIENCES INC | INBX | 0.33% |
GERON CORP | GERN | 0.33% |
JADE BIOSCIENCES INC | JBIO | 0.33% |
MONTE ROSA THERAPEUTICS INC | GLUE | 0.32% |
MANNKIND CORP | MNKD | 0.32% |
SIONNA THERAPEUTICS INC | SION | 0.31% |
OLEMA PHARMACEUTICALS INC | OLMA | 0.31% |
JANUX THERAPEUTICS INC | JANX | 0.3% |
BICARA THERAPEUTICS INC | BCAX | 0.29% |
KURA ONCOLOGY INC | KURA | 0.28% |
ARRIVENT BIOPHARMA INC | AVBP | 0.26% |
CYTOMX THERAPEUTICS INC | CTMX | 0.26% |
RIGEL PHARMACEUTICALS INC | RIGL | 0.25% |
ALTIMMUNE INC | ALT | 0.24% |
SANA BIOTECHNOLOGY INC | SANA | 0.23% |
ALLOGENE THERAPEUTICS INC | ALLO | 0.23% |
IRONWOOD PHARMACEUTICALS INC | IRWD | 0.23% |
SOLID BIOSCIENCES INC | SLDB | 0.22% |
REGENXBIO INC | RGNX | 0.22% |
CANDEL THERAPEUTICS INC | CADL | 0.21% |
DAMORA THERAPEUTICS INC | DMRA | 0.21% |
IMMIX BIOPHARMA INC | IMMX | 0.21% |
VERASTEM INC | VSTM | 0.19% |
SAVARA INC | SVRA | 0.18% |
OCUGEN INC | OCGN | 0.17% |
4D MOLECULAR THERAPEUTICS IN | FDMT | 0.17% |
ARBUTUS BIOPHARMA CORP | ABUS | 0.16% |
PRIME MEDICINE INC | PRME | 0.15% |
CABALETTA BIO INC | CABA | 0.14% |
COMPASS THERAPEUTICS INC | CMPX | 0.13% |
OVID THERAPEUTICS INC | OVID | 0.13% |
ARS PHARMACEUTICALS INC | SPRY | 0.12% |
PROTHENA CORP PLC | PRTA | 0.12% |
MIMEDX GROUP INC | MDXG | 0.12% |
PERSPECTIVE THERAPEUTICS INC | CATX | 0.12% |
VANDA PHARMACEUTICALS INC | VNDA | 0.11% |
LEXEO THERAPEUTICS INC | LXEO | 0.11% |
MYRIAD GENETICS INC | MYGN | 0.09% |
CAPRICOR THERAPEUTICS INC | CAPR | 0.09% |
EMERGENT BIOSOLUTIONS INC | EBS | 0.09% |
ACHIEVE LIFE SCIENCES INC | ACHV | 0.09% |
SAGIMET BIOSCIENCES INC A | SGMT | 0.08% |
CONTRA METSERA INC | CONTRA.METSERA.INC | 0.07% |
BRIDGEBIO ONCOLOGY THERAPEUT | BBOT | 0.07% |
SSI US GOV MONEY MARKET CLASS | SSI.US.GOV.MONEY.MARKET.CLASS | 0.07% |
MAPLIGHT THERAPEUTICS INC | MPLT | 0.06% |
CONTRA AKERO THERAPEUT | CONTRA.AKERO.THERAPEUT | 0.01% |
CONTRA INHIBRX INC | CONTRA.INHIBRX.INC | 0.01% |
CONTRA MIRATI THERAPEU | CONTRA.MIRATI.THERAPEU | 0.01% |
CONTRA VERVE THERAPEUT | CONTRA.VERVE.THERAPEUT | 0.01% |
CONTRA BLUEPRINT MEDIC | CONTRA.BLUEPRINT.MEDIC | 0% |
US DOLLAR | US.DOLLAR | 0% |
OMNIAB INC 15.00 EARNOUT | 2200964D | 0% |
OMNIAB INC 12.5 EARNOUT | 2200963D | 0% |
| Sector | Weight |
|---|---|
|
Health care | 99.57% |
|
Financials | 0.43% |
SPDR® S&P Biotech ETF (XBI) share price today is $159.85.
Yes, Indians can buy shares of SPDR® S&P Biotech ETF (XBI) on Vested. To buy XBI from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of SPDR® S&P Biotech ETF (XBI) on Vested. You can start investing in SPDR® S&P Biotech ETF (XBI) with a minimum investment of $1.
The 52-week high price of SPDR® S&P Biotech ETF (XBI) is $165.71. The 52-week low price of SPDR® S&P Biotech ETF (XBI) is $87.78.
The stock symbol (or ticker) of SPDR® S&P Biotech ETF is XBI.
Yes, you can setup SIP in SPDR® S&P Biotech ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of XBI on the Vested app.
The expense ratio of SPDR® S&P Biotech ETF (XBI) is 0.35%.
Link copied